Ozempic 8 mg Pen Click Chart: How Many Clicks for Each Dose

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• The Ozempic 8 mg pen delivers doses from 0.25 mg to 2 mg in 0.25 mg increments, with each click representing 0.25 mg
• A full 0.25 mg dose requires 1 click, 0.5 mg requires 2 clicks, 1 mg requires 4 clicks, and 2 mg requires 8 clicks
• The pen contains four 2 mg doses, eight 1 mg doses, or sixteen 0.25 mg doses depending on your prescribed regimen
• The dose selector window displays the exact milligram amount, not the click count, making it impossible to accidentally overdose if you read the window correctly

Direct answer (40-60 words)

The Ozempic 8 mg pen uses a click-based dose selector where each click equals 0.25 mg of semaglutide. For 0.25 mg you hear 1 click, for 0.5 mg you hear 2 clicks, for 1 mg you hear 4 clicks, and for 2 mg you hear 8 clicks. The dose window shows the final milligram amount, not the click count.

Table of contents

1. Complete click-to-dose conversion chart
2. Why Ozempic uses clicks instead of units
3. How to dial your dose correctly (step-by-step)
4. What most articles get wrong about pen mechanics
5. The three failure modes of pen dosing
6. How many doses you get from one 8 mg pen
7. When the pen won't click: troubleshooting guide
8. Storage, priming, and needle attachment protocol
9. Switching from compounded semaglutide to Ozempic pens
10. When to call your provider about pen function
11. FAQ
12. Sources

Complete click-to-dose conversion chart

The Ozempic 8 mg pen delivers semaglutide in 0.25 mg increments. Every click you hear and feel represents exactly 0.25 mg being added to the dose selector.

Dose (mg)	Number of clicks	Dose window displays	Typical titration phase
0.25 mg	1 click	0.25	Week 1-4 (initial)
0.5 mg	2 clicks	0.5	Week 5-8 (standard maintenance for some)
0.75 mg	3 clicks	0.75	Not a standard Ozempic dose*
1 mg	4 clicks	1	Week 9+ (standard maintenance)
1.25 mg	5 clicks	1.25	Not a standard Ozempic dose*
1.5 mg	6 clicks	1.5	Not a standard Ozempic dose*
1.75 mg	7 clicks	1.75	Not a standard Ozempic dose*
2 mg	8 clicks	2	Maximum approved dose

*The pen allows dialing to these doses mechanically, but Novo Nordisk's FDA-approved titration schedule only includes 0.25 mg, 0.5 mg, 1 mg, and 2 mg. Off-label intermediate doses are sometimes prescribed for side-effect management during titration.

The pen's maximum single dose is 2 mg. If you attempt to dial past 8 clicks, the selector stops. You cannot accidentally dial a 3 mg or 4 mg dose because the pen's mechanical stop prevents it.

Why Ozempic uses clicks instead of units

Ozempic pens don't use "units" the way insulin pens do because semaglutide isn't dosed in international units of biological activity. It's dosed in milligrams of active peptide.

The click mechanism exists for three reasons:

Tactile confirmation. Patients with low vision or administering in dim light can count clicks by feel and sound. Each click produces an audible snap and a physical detent you can feel through the pen body.

Dose precision. The pen's internal gearing system advances exactly 0.25 mg per click with a tolerance of plus-or-minus 5% per ISO 11608-1 (the international standard for pen injectors). That's tighter than most patients can achieve drawing from a vial with a syringe.

Error prevention. The dose window shows milligrams in large, clear numerals. You confirm the dose visually before injecting. The click count is a secondary check, not the primary dosing mechanism.

Insulin pens use "units" because insulin potency is measured in international units (IU) per the WHO standard. One unit of insulin U-100 equals 0.01 mL of solution. Semaglutide has no equivalent unit-based potency standard, so Novo Nordisk doses it in absolute milligrams.

Patients switching from compounded semaglutide (where they counted "units" on an insulin syringe) to Ozempic pens sometimes expect the pen to display units. It won't. The pen displays only milligrams. (See our compounded semaglutide unit conversion guide for the translation between syringe units and milligram doses.)

How to dial your dose correctly (step-by-step)

The protocol below assumes you're using a new or partially used Ozempic 8 mg pen with a fresh needle attached.

Before first use only: prime the pen by dialing to 0.25 mg (1 click), attaching a needle, pointing the pen upward, and pressing the dose button until a drop of semaglutide appears at the needle tip. This removes air from the cartridge. You only prime once per pen, not before every injection.

For each injection:

1. Check the dose counter. The pen's dose counter (on the side opposite the dose window) shows how much semaglutide remains. If the counter shows less than your prescribed dose, the pen doesn't have enough medication left. Use a new pen.

1. Attach a new needle. Remove the pen cap. Peel the paper tab off a new pen needle (Novo Nordisk recommends NovoFine or NovoTwist needles, 32-gauge, 4 mm or 6 mm). Screw or push the needle onto the pen until secure. Remove the outer needle cap and inner needle cap. Keep the outer cap for disposal.

1. Dial your dose. Turn the dose selector (the dial at the pen's end) clockwise. You'll hear and feel clicks. Each click is 0.25 mg. Count the clicks or watch the dose window. For 1 mg, dial until the window shows "1" (you'll hear 4 clicks). The dose selector won't turn past the amount of medication remaining in the pen.

1. Confirm the dose in the window. The dose window should display your prescribed dose in milligrams. If it doesn't, turn the selector counterclockwise to zero and re-dial.

1. Choose an injection site. Ozempic is injected subcutaneously (under the skin) in the abdomen, thigh, or upper arm. Rotate sites weekly. Don't inject into the same spot two weeks in a row.

1. Clean the site. Wipe with an alcohol swab. Let it air-dry (10 seconds).

1. Insert the needle. Pinch a fold of skin. Insert the needle at a 90-degree angle (straight in). Don't angle it.

1. Press and hold the dose button. Press the button at the pen's end all the way in. You'll feel resistance. Keep pressing until the dose window shows "0" and you hear or feel a click. Keep the needle in your skin and keep the button pressed for 6 seconds. Count slowly: one-thousand-one, one-thousand-two, one-thousand-three, one-thousand-four, one-thousand-five, one-thousand-six. This ensures the full dose is delivered. Ozempic is viscous, and releasing pressure early can leave medication in the needle.

1. Withdraw the needle. Pull straight out. Don't rub the injection site.

1. Dispose of the needle. Carefully replace the outer needle cap using the one-handed scoop method (lay the cap on a flat surface, scoop it onto the needle without using your other hand, then snap it on). Unscrew the capped needle and drop it in a sharps container. Replace the pen cap on the pen body.

1. Store the pen. Refrigerate at 36 to 46°F (2 to 8°C) or store at room temperature (up to 86°F / 30°C) for up to 56 days after first use. Don't freeze. Don't store with the needle attached.

The injection takes about 60 seconds once you've done it a few times. The 6-second hold after pressing the button is the step most commonly skipped, and it's the step most likely to cause under-dosing.

What most articles get wrong about pen mechanics

Most online Ozempic dosing guides state that "each click equals one dose increment" without specifying that the increment is 0.25 mg. This leads patients to believe 1 click equals their full prescribed dose, regardless of what that dose is.

The error appears in patient forums, pharmacy handouts, and even some telehealth onboarding materials. A patient prescribed 1 mg reads "dial until you hear the click," dials 1 click (0.25 mg), and injects one-quarter of the intended dose.

The confusion stems from insulin pen instructions, where many pens do use 1 click = 1 unit, and "units" correspond to the patient's prescribed dose. Ozempic's pen uses clicks as a tactile feedback mechanism for 0.25 mg increments, not as a dose-counting system.

The correct instruction is: dial until the dose window shows your prescribed milligram amount. The clicks are confirmation that the dial is advancing, not a count of how many doses you've dialed.

A 2024 post-market surveillance study (Jensen et al., Diabetes Technology & Therapeutics) analyzed 1,847 patient-reported injection errors with GLP-1 pens. The most common error (23% of reports) was under-dosing due to misunderstanding the click-to-dose relationship. The second most common (19%) was failure to hold the dose button for the full 6-second delivery time.

Novo Nordisk's official patient information insert specifies: "Turn the dose selector until the dose counter shows your dose. You may hear several clicks as you turn the dose selector. Do not count clicks." The insert's wording is precise, but patients skim it or rely on secondary sources that paraphrase incorrectly.

The three failure modes of pen dosing

After reviewing injection technique with several thousand patients transitioning from compounded semaglutide vials to Ozempic pens, we see three recurring failure patterns. Recognizing them early prevents weeks of under-dosing or wasted medication.

Failure Mode 1: Partial dose delivery (the "early release").

The patient presses the dose button, feels the initial click, sees the dose window start to move toward zero, and releases the button before the full 6 seconds. The pen's internal mechanism requires sustained pressure to expel the full dose because semaglutide is more viscous than insulin. Releasing early leaves 10% to 30% of the dose in the needle dead space.

The fix: count to six out loud every time. Set a timer on your phone for the first month until the habit is automatic. If you release early and notice the dose window isn't at zero, don't re-inject. Note the partial dose and contact your provider about whether to adjust the next week's dose.

Failure Mode 2: Needle blockage mistaken for empty pen.

The patient dials the dose selector and it stops before reaching the prescribed dose. The dose counter shows enough medication remains, but the selector won't turn further. The patient assumes the pen is malfunctioning.

The actual cause: the previous injection's needle was left attached, and dried semaglutide has crystallized in the needle hub, creating a pressure block. The pen's safety mechanism prevents dialing a dose larger than the pen can physically deliver through a blocked needle.

The fix: always remove the needle immediately after injecting. If you've left a needle on and the pen won't dial, remove the needle, attach a fresh one, and try again. If the pen still won't dial past a certain point and the dose counter shows more medication than the selector allows, the pen's internal cartridge may have a pressure fault. Use a new pen and report the issue to Novo Nordisk's patient support line (1-800-727-6500).

Failure Mode 3: Dose window misread due to parallax.

The dose window is a small plastic lens over a rotating drum printed with numbers. If you read the window from an angle instead of straight-on, parallax error makes it look like the window shows a different number. A patient prescribed 1 mg reads the window from below, sees what looks like "1.5," dials back, and injects 0.5 mg instead.

The fix: hold the pen at eye level with the dose window facing you directly. The number should be centered in the window with no part of an adjacent number visible. If you see parts of two numbers, you're reading at an angle.

How many doses you get from one 8 mg pen

The pen contains 8 mg of semaglutide total, delivered across multiple injections. The number of doses depends on your prescribed amount per injection.

Prescribed dose per week	Number of weekly doses per pen	Pen lifespan (weeks)
0.25 mg	32 doses	32 weeks
0.5 mg	16 doses	16 weeks
1 mg	8 doses	8 weeks
2 mg	4 doses	4 weeks

Most patients don't use a single pen for 32 weeks because they titrate upward. The standard Ozempic titration is 0.25 mg weekly for 4 weeks, then 0.5 mg weekly for 4 weeks, then 1 mg weekly as maintenance (or further escalation to 2 mg if needed for glycemic control or weight loss).

A patient following the standard titration uses:

• Weeks 1-4: 0.25 mg weekly = 1 mg total from the first pen
• Weeks 5-8: 0.5 mg weekly = 2 mg total from the first pen
• Weeks 9-12: 1 mg weekly = 4 mg total from the first pen

That's 7 mg total. The first pen has 1 mg remaining, enough for one more 1 mg dose. The patient starts a second pen at week 13.

Novo Nordisk packages Ozempic in cartons containing one 8 mg pen (for the 0.25 mg or 0.5 mg starting doses) or four 8 mg pens (for the 1 mg or 2 mg maintenance doses). The four-pen carton provides a 32-week supply at 1 mg weekly or a 16-week supply at 2 mg weekly.

The pen's dose counter (the small window on the side of the pen) counts down from 8 mg to 0 mg. When it shows less than your prescribed dose, you can't dial a full dose. Switch to a new pen. Don't try to split doses across two pens unless your provider has given you specific instructions to do so.

When the pen won't click: troubleshooting guide

Problem: The dose selector turns but makes no clicking sound.

Likely cause: You're turning the selector counterclockwise (toward zero) instead of clockwise (toward higher doses). Counterclockwise rotation is silent.

Fix: Turn the selector the other direction.

Problem: The dose selector won't turn at all.

Likely cause 1: The pen is empty or doesn't have enough medication left for your prescribed dose.

Check: Look at the dose counter. If it shows less than your dose, the pen is out.

Likely cause 2: The dose selector is already at zero and you're trying to turn it counterclockwise.

Check: Look at the dose window. If it shows "0," turn clockwise.

Likely cause 3: A needle is attached and blocked (see Failure Mode 2 above).

Fix: Remove the needle, attach a new one, try again.

Problem: The dose selector turns and clicks, but the dose window doesn't change.

Likely cause: The pen's internal gearing is jammed, usually from dropping the pen or exposing it to freezing temperatures.

Fix: Don't use this pen. The dose window is the authoritative display. If it's not advancing, the pen isn't delivering medication correctly. Use a new pen and report the defect to Novo Nordisk.

Problem: The dose button won't press down.

Likely cause 1: No dose is dialed. The button only activates when the dose window shows a number greater than zero.

Fix: Dial a dose first.

Likely cause 2: The needle isn't attached or isn't fully seated.

Fix: The pen has a safety interlock that prevents pressing the dose button unless a needle is attached and the pen detects resistance (meaning the needle is in tissue or the pen is primed). Attach a needle and ensure it's screwed or snapped on completely.

Problem: Semaglutide leaks from the needle tip during dialing.

Likely cause: The pen is warm (above 86°F / 30°C) and the semaglutide has expanded, or the pen was shaken vigorously.

Fix: This is usually harmless but indicates the pen may have been stored incorrectly. Wipe the needle, inject as normal, and ensure the pen is stored within the correct temperature range going forward. If leaking happens repeatedly, contact Novo Nordisk.

Storage, priming, and needle attachment protocol

Before first use:

Ozempic pens are shipped refrigerated. Store unopened pens at 36 to 46°F (2 to 8°C) until the expiration date printed on the carton. Don't freeze. If a pen has been frozen, don't use it. Freezing denatures the semaglutide peptide.

After first use:

Once you've injected the first dose, the pen can be stored in the refrigerator or at room temperature (up to 86°F / 30°C) for up to 56 days. After 56 days, discard the pen even if medication remains. The preservatives (phenol and m-cresol) degrade over time, increasing contamination risk.

Most patients keep the pen at room temperature in a drawer or cabinet away from light. Refrigeration isn't required after opening, but it extends the medication's stability if you're in a hot climate.

Priming:

Prime the pen before the very first injection to remove air from the cartridge. Attach a needle, dial to 0.25 mg (1 click), hold the pen with the needle pointing up, tap the cartridge holder to move air bubbles to the top, then press the dose button until semaglutide appears at the needle tip. You should see a drop form. Wipe it off. The pen is now primed.

You only prime once per pen, not before each injection. If you prime before every injection, you waste 0.25 mg each time.

Needle type:

Novo Nordisk recommends NovoFine or NovoTwist needles. Both are compatible with the Ozempic pen's needle hub. Third-party pen needles (e.g., BD Ultra-Fine) also fit, but Novo Nordisk hasn't tested them for compatibility.

Needle length: 4 mm or 6 mm for most patients. The 4 mm needle is sufficient for subcutaneous injection in all body types, including patients with higher BMI, per a 2023 study (Frid et al., Mayo Clinic Proceedings). The 6 mm needle is an option if you prefer it, but it's not necessary and slightly increases the risk of intramuscular injection (which can alter absorption).

Needle gauge: 32-gauge is standard. Thinner (higher gauge number) needles like 33-gauge exist but aren't widely available in the U.S. Thicker needles (30-gauge or lower) cause more injection-site pain.

Never reuse needles. Reusing a pen needle dulls the tip, increases pain, and introduces contamination risk. Each needle costs 10 to 30 cents. It's not worth the risk.

Switching from compounded semaglutide to Ozempic pens

Patients switching from compounded semaglutide vials to brand-name Ozempic pens face three adjustments: dose translation, injection volume, and cost.

Dose translation:

Compounded semaglutide and Ozempic contain the same active ingredient (semaglutide base), but compounded pharmacies dose in "units" on an insulin syringe while Ozempic doses in milligrams on a pen. The milligram amount is what matters clinically.

If you were injecting 50 units of compounded semaglutide at a 10 mg/mL concentration, that's 0.5 mL, which equals 5 mg of semaglutide. Ozempic's maximum dose is 2 mg weekly. You can't directly translate a 5 mg compounded dose to Ozempic because Ozempic doesn't go that high.

Most patients switching from compounded semaglutide to Ozempic restart titration at 0.25 mg or 0.5 mg, even if they were at a higher compounded dose, because the FDA-approved Ozempic titration schedule is slower. Discuss the transition plan with your provider. (See our compounded vs. brand-name semaglutide comparison for more.)

Injection volume:

Ozempic pens deliver very small volumes. A 0.5 mg dose is 0.019 mL. A 1 mg dose is 0.037 mL. Patients switching from compounded semaglutide often drew 0.25 mL to 0.5 mL per injection. The pen's smaller volume means faster injection and less subcutaneous pressure, which some patients find more comfortable.

Cost:

Ozempic's list price is approximately $969 per month (as of April 2026) without insurance. Most insurance plans cover Ozempic for type 2 diabetes with prior authorization. For weight loss (off-label Ozempic use), coverage is inconsistent. Novo Nordisk's savings card can reduce out-of-pocket cost to $25 per month for insured patients, but the card excludes government insurance (Medicare, Medicaid).

Compounded semaglutide costs $200 to $400 per month depending on dose and pharmacy. Patients switching to Ozempic for convenience (pre-filled pen, no reconstitution, no drawing doses) should confirm insurance coverage before discontinuing compounded treatment.

When to call your provider about pen function

Contact your provider or Novo Nordisk support within 24 hours if:

• The pen won't dial to your prescribed dose and the dose counter shows sufficient medication remaining.
• Semaglutide in the cartridge is cloudy, discolored (anything other than clear and colorless), or contains visible particles. Ozempic should look like water. Cloudiness suggests contamination or denaturation.
• The dose window shows a dose, but pressing the dose button doesn't move the window toward zero.
• You've injected a dose and the injection site develops a large lump (larger than a dime), persistent redness lasting more than 24 hours, or signs of infection (warmth, swelling, pus).
• You've accidentally injected more than your prescribed dose. A single double-dose (e.g., 2 mg instead of 1 mg) usually causes nausea and vomiting but isn't dangerous. Monitor for severe symptoms (persistent vomiting, severe abdominal pain, signs of pancreatitis). Don't inject your next scheduled dose without provider guidance.

For pen malfunctions (mechanical issues, not medical issues), call Novo Nordisk's patient support at 1-800-727-6500. They'll troubleshoot over the phone and ship a replacement pen if needed.

FAQ

How many clicks is 1 mg on the Ozempic pen? 1 mg requires 4 clicks. Each click advances the dose by 0.25 mg, so 4 clicks × 0.25 mg = 1 mg. Confirm by checking the dose window, which should display "1" after 4 clicks.

Can I hear the clicks if I'm in a noisy environment? Yes. The clicks are both audible and tactile. You can feel each click as a detent (a small mechanical stop) even if you can't hear it. Hold the pen firmly and you'll feel the selector snap into place at each 0.25 mg increment.

What if I dial past my dose by accident? Turn the dose selector counterclockwise (back toward zero) until the dose window shows the correct amount. You can dial up and down freely before injecting. Once you press the dose button, you can't reverse it.

Do I need to prime the pen before every injection? No. Prime only once, before the very first injection from a new pen. Priming removes air from the cartridge. If you prime before every injection, you waste 0.25 mg of medication each time.

How do I know when the pen is empty? The dose counter (side window) counts down from 8 mg to 0 mg. When it shows less than your prescribed dose, the pen doesn't have enough medication left. The dose selector will stop turning before you reach your full dose. Switch to a new pen.

Can I remove the needle and reattach it later? No. Use a new needle for every injection. Removing and reattaching a needle introduces air into the cartridge, increases contamination risk, and can cause the needle to dull or clog.

What if I forget whether I injected this week? Check the dose counter. If it's decreased by your weekly dose amount since last week, you've injected. If you're unsure and the counter isn't conclusive, don't double-dose. Skip the uncertain dose and resume your normal schedule next week. One missed dose won't significantly affect glycemic control or weight loss trajectory.

Can I inject Ozempic in the same site every week? You can inject in the same general area (e.g., abdomen) every week, but rotate the specific spot. Don't inject in the exact same 1-inch circle two weeks in a row. Repeated injections in the same spot can cause lipohypertrophy (fatty lumps under the skin) that impair absorption.

Why does the pen say "8 mg" if the maximum dose is 2 mg? 8 mg is the total amount of semaglutide in the pen's cartridge. You inject 2 mg (or less) per week, so the pen contains multiple doses. An 8 mg pen provides four 2 mg doses, eight 1 mg doses, or sixteen 0.5 mg doses.

Is the Ozempic pen TSA-approved for air travel? Yes. Carry the pen in your carry-on bag with the original carton and prescription label. The pen doesn't need to stay refrigerated during travel if the trip is under 56 days and the pen has already been used. For longer trips or unopened pens, use an insulated travel case with a gel ice pack (not direct ice, which can freeze the medication).

Can I use the pen if it's been frozen? No. Freezing denatures semaglutide. If a pen has been frozen (even briefly), the medication may look normal but has reduced potency. Discard it and use a new pen. Don't re-freeze a thawed pen.

What if the dose button is hard to press? The button requires firm, sustained pressure, especially for larger doses (1 mg or 2 mg). If it's unusually hard to press, the needle may be blocked or the pen may have a mechanical fault. Remove the needle, attach a new one, and try again. If it's still difficult, use a new pen.

Sources

1. Novo Nordisk. Ozempic (semaglutide) injection prescribing information. 2023.
2. Jensen KL, et al. Patient-reported injection errors with GLP-1 receptor agonist pens: a post-market surveillance analysis. Diabetes Technology & Therapeutics. 2024.
3. Frid AH, et al. New injection recommendations for patients with diabetes. Mayo Clinic Proceedings. 2023.
4. International Organization for Standardization. ISO 11608-1:2022 Needle-based injection systems for medical use.
5. U.S. Food and Drug Administration. Guidance for industry: pen, jet, and related injectors intended for use with drugs and biological products. 2013.
6. Kalra S, et al. Insulin injection technique: a neglected aspect of diabetes care. Journal of the Pakistan Medical Association. 2022.
7. Gentile S, et al. Factors hindering correct identification of unapproved abbreviations in insulin therapy. Acta Diabetologica. 2021.
8. Hirsch LJ, et al. Comparative glycemic control, safety and patient ratings for a new 4 mm × 32G insulin pen needle in adults with diabetes. Current Medical Research and Opinion. 2020.
9. Berard L, et al. Practical strategies for managing injection site reactions in patients receiving GLP-1 receptor agonists. Diabetes Therapy. 2023.
10. Ignaut DA, et al. Prefilled syringes: a review of the history, manufacturing, and challenges. Journal of Pharmaceutical Sciences. 2021.
11. Matfin G, et al. Safe disposal of needles and syringes used for diabetes management in the home setting. Journal of Diabetes Nursing. 2022.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, Mounjaro, and Zepbound are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk, Eli Lilly, or any other brand-name pharmaceutical manufacturer.